![]() Over the last decades, significant changes have been made to antiplatelet therapeutic and prophylactic strategies. 6Service d'Hématologie Biologique, AP-HP, Université de Paris, Hôpital Européen Georges Pompidou, Paris, FranceĪntiplatelet agents, with aspirin and P2Y 12 receptor antagonists as major key molecules, are currently the cornerstone of pharmacological treatment of atherothrombotic events including a variety of cardio- and cerebro-vascular as well as peripheral artery diseases.5Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.4Department of Anesthesiology and Critical Care, AP-HP, Université de Paris, Hôpital Européen Georges Pompidou, Paris, France.3Université de Paris, Innovative Therapies in Haemostasis, INSERM UMR_S1140, Paris, France. ![]()
0 Comments
Leave a Reply. |